Eli Lilly and Co logo

Eli Lilly and Co - Cedear

NEW
BUE:LLY (USA)   Cedear
ARS 35,740 +480 (+1.36%) Aug 21
42.13
P/B:
33.04
Market Cap:
ARS 1,675.46T ($ 1.12T)
Enterprise V:
ARS 1,744.27T ($ 1.16T)
Volume:
8.47K
Avg Vol (2M):
11.61K
Trade In:
Volume:
8.47K
Avg Vol (2M):
11.61K

Eli Lilly and Co’s share price is ARS35740. Its GF Value is ARS43092.3. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Eli Lilly and Co stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: ARS35740 GF Value Price/GF Value
Current ARS43092.3 0.83
Next FY1 End ARS47693.38 0.75
Next 12 Month ARS52556.71 0.68
Next FY2 End ARS54998.38 0.65
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing Eli Lilly and Co's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The findings reveal that Eli Lilly and Co's stock price shows no significant correlation with any of these four metrics.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies